Trial intelligence / Profile preview

Metformin with Insulin in Uncontrolled Diabetic Pregnancy

NCT05479214Phase 4Completed

Sponsor
Cairo University
Start
Jul 2022
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of liquid metformin (Aspargo Labs) in gestational diabetes mellitus (GDM), type 2 diabetes mellitus (T2DM), sponsored by Cairo University. Started Jul 2022; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

gestational diabetes mellitus (GDM)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT05479214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05479214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call